New Zealand markets closed

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
79.46+0.63 (+0.80%)
At close: 04:02PM EST
79.30 -0.16 (-0.20%)
After hours: 07:59PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
52,607,000
47,994,000
46,840,000
42,294,000
Cost of revenue
16,648,000
15,485,000
14,112,000
13,509,000
Gross profit
35,959,000
32,509,000
32,728,000
28,785,000
Operating expenses
Research development
15,126,000
13,558,000
9,872,000
9,752,000
Selling general and administrative
10,936,000
10,468,000
10,615,000
10,102,000
Total operating expenses
26,062,000
24,026,000
20,487,000
19,854,000
Operating income or loss
9,897,000
8,483,000
12,241,000
8,931,000
Interest expense
804,000
831,000
893,000
772,000
Total other income/expenses net
1,222,000
1,080,000
-158,000
199,000
Income before tax
10,353,000
8,791,000
11,464,000
8,701,000
Income tax expense
1,874,000
1,709,000
1,687,000
2,508,000
Income from continuing operations
8,479,000
7,082,000
9,777,000
6,193,000
Net income
7,197,000
7,067,000
9,843,000
6,220,000
Net income available to common shareholders
7,197,000
7,067,000
9,843,000
6,220,000
Basic EPS
-
2.79
3.88
2.40
Diluted EPS
-
2.78
3.81
2.32
Basic average shares
-
2,530,226
2,539,016
2,592,560
Diluted average shares
-
2,541,000
2,580,000
2,679,000
EBITDA
-
13,247,000
16,009,000
13,992,000